Jump to content
Wikipedia The Free Encyclopedia

Tibotec

From Wikipedia, the free encyclopedia
Tibotec
IndustryPharmaceutical
Founded1994; 31 years ago (1994)
Founders
  • Rudi Pauwels
  • Carine Claeys
  • Marie-Pierre de Béthune
  • Kurt Hertogs
  • Hilde Azijn
Defunct2002 (2002)
FateAcquired by Johnson & Johnson and merged into its Janssen Pharmaceuticals division
Websitetibotec.com

Tibotec was a pharmaceutical company with a focus on research and development of the treatment of infectious diseases such as HIV/AIDS and hepatitis C. The company was founded in 1994 and then acquired by Johnson & Johnson and merged into its Janssen Pharmaceuticals division in 2002. The company is part of Johnson & Johnson Innovation Medicine business segment.

The name of the company is derived from the tetrahydro-imidazo[4,5,1-jk][1,4]-benzodiazepine-2(1H)-one and -thione (TIBO) compounds discovered at the Rega Institute for Medical Research (Belgium).[1]

History

[edit ]

In 1994, Rudi Pauwels of the Rega Institute for Medical Research founded Tibotec, together with his wife Carine Claeys, and their first co-workers Marie-Pierre de Béthune, Kurt Hertogs, and Hilde Azijn. In 1995 Paul Stoffels joined Tibotec. The company was acquired by Johnson & Johnson in April 2002,[2] and was renamed Janssen Therapeutics in June 2011.[3]

Tibotec provided funding for HIV treatment clinical trials at the Infectious Diseases Institute in Kampala, Uganda.[4] [5]

Drugs

[edit ]

See also

[edit ]

References

[edit ]
  1. ^ Pauwels, Rudi; Andries, Koen; Desmyter, Jan; Schols, Dominique; Kukla, Michael J.; Breslin, Henry J.; Raeymaeckers, Alfons; Gelder, Jozef Van; Woestenborghs, Robert; Heykants, Jozef; Schellekens, Karel; Janssen, Marcel A. C.; Clercq, Erik De; Janssen, Paul A. J. (1990). "Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives". Nature. 343 (6257): 470–474. Bibcode:1990Natur.343..470P. doi:10.1038/343470a0. PMID 1689015. S2CID 4354080.
  2. ^ "Johnson & Johnson to Acquire Tibotec-Virco". Johnson & Johnson . 2002年03月22日. Archived from the original on 2002年06月08日. Retrieved 2023年05月16日.
  3. ^ Van Houten, Pamela (2011年06月22日). "Tibotec Therapeutics Becomes Janssen Therapeutics, Part Of The Janssen Pharmaceutical Companies". Johnson & Johnson . Archived from the original on 2023年05月17日. Retrieved 2023年05月17日.
  4. ^ Schmickle, Sharon (2008年11月13日). "University of Minnesota doctors battle AIDS in Uganda". MinnPost . Archived from the original on 2010年06月23日. Retrieved 2023年05月16日.
  5. ^ "Clinical Research at the Infectious Diseases Institute" (PDF). The Global Health Network. Infectious Diseases Institute. Archived (PDF) from the original on 2023年05月17日. Retrieved 2023年05月17日.
  6. ^ Andries, K.; Verhasselt, P; Guillemont, J; Göhlmann, H. W.; Neefs, J. M.; Winkler, H; Van Gestel, J; Timmerman, P; Zhu, M; Lee, E; Williams, P; De Chaffoy, D; Huitric, E; Hoffner, S; Cambau, E; Truffot-Pernot, C; Lounis, N; Jarlier, V (2005). "A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis". Science. 307 (5707): 223–7. Bibcode:2005Sci...307..223A. doi:10.1126/science.1106753 . PMID 15591164. S2CID 33219841.
  7. ^ Zeuzem S, Berg T, Gane E, et al. (2012). TMC435 in HCV Genotype 1 Patients Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment: Final SVR24 Results of the ASPIRE Trial. 47th Annual Meeting of the European Association for the Study of the Liver. Barcelona, April 18–22, 2012. Abstract 2.
[edit ]
Product
brands
Innovative medicine
Medtech
Companies
Subsidiaries
Innovative medicine
Medtech
Acquisitions
Partnerships
People
Executives and scientists
Board of directors
Founders
Former executives,
board members,
and scientists
Former
subsidiaries
Legacy
brands
Buildings
Related

AltStyle によって変換されたページ (->オリジナル) /